Medications associated with Lung Cancer
Ingredients whose current FDA labeling lists an association with lung cancer, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Brigatinib
ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metas...
Capmatinib
TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) w...
Ceritinib
ZYKADIA® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) w...
Dacomitinib Anhydrous
VIZIMPRO is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSC...
Ensartinib
ENSACOVE is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive local...
Etoposide
VePesid (etoposide) is indicated in the management of: Small Cell Lung Cancer— VePesid Capsules in combination...
Gallium Cation Ga-67
Gallium Citrate Ga 67 Injection may be useful to demonstrate the presence and extent of Hodgkin's disease, lym...
Gefitinib
Gefitinib tablets are indicated for the first-line treatment of patients with metastatic non-small cell lung c...
Lazertinib
LAZCLUZE, in combination with amivantamab, is indicated for the first-line treatment of adult patients with lo...
Lorlatinib
LORBRENA® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) ...
Paclitaxel
Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ov...
Sevabertinib
HYRNUO is indicated for the treatment of adult patients with locally advanced or metastatic non-squamous non-s...
Taletrectinib
IBTROZI® (taletrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ...
Tarlatamab
IMDELLTRA is indicated for the treatment of adult patients with extensive stage small cell lung cancer (ES-SCL...
Telisotuzumab Vedotin
EMRELIS is indicated for the treatment of adult patients with locally advanced or metastatic, non-squamous non...
Tepotinib
TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) h...
Topotecan
Topotecan Injection is indicated for the treatment of: small cell lung cancer sensitive disease after failure ...
Trilaciclib
COSELA is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when ...
Vinorelbine
Vinorelbine injection is indicated: In combination with cisplatin for first-line treatment of patients with lo...
Zidesamtinib
JIDEYTRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1 -positive n...
Zongertinib
HERNEXEOS is indicated for the treatment of adult patients with unresectable or metastatic non-squamous non-sm...
Lab tests that investigate lung cancer
Alpha-Fetoprotein Afp Tumor Marker Test
This blood test determines Alpha-Fetoprotein (AFP or a-Fetoprotein) levels....
CBC with Differential
Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...
Cancer & Tumor Marker Tests
Fast, easy and affordable cancer lab tests that do not require insurance or a doctor's referral. Simply order ...
Comprehensive Metabolic Panel (CMP)
Measures 14 substances in the blood to assess kidney and liver function, electrolyte balance, and blood sugar ...
Ovarian Cancer Blood Test
The Cancer Antigen 125 (CA-125) test is used to evaluate the blood for CA-125, a cancer tumor marker. CA-125 i...
Frequently Asked Questions
What medications are used for lung cancer?
The medications listed above are associated with lung cancer in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure lung cancer?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.